MedCity News November 17, 2021
The results, shared at AHA 2021, found that a third of adults who used an ECG patch after getting a heart rhythm notification from their Fitbit had atrial fibrillation. However, the study faced some challenges with adherence, as many patients who got a notification did not follow up.
Results of a massive, 455,000-person study shared this week point to Fitbit’s ability to detect atrial fibrillation. But like its peers, it still faces challenges with clinical implementation.
Fitbit received FDA clearance for its atrial fibrillation (AFib) feature last year, which uses a built-in ECG sensor to detect potential arrhythmias, though it can’t provide a diagnosis.
Researchers at Mass General Brigham began enrolling last year for the Fitbit Heart study, a large,...